why choose us

First received: February 21, 2024

Clinical Trial: COVID-19 Antibody Responses In Cystic Fibrosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: OBSERVATIONAL


Official Title: COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF

Brief Summary: Coronavirus disease 2019 (COVID-19) which is caused by the virus SARS-CoV-2 has resulted in an ongoing global pandemic.It is unclear whether the relatively low number of reported cases of COVID-19 in people with CF (pwCF) is due to enhanced infection prevention practices or whether pwCF have protective genetic/immune factors.This study aims to prospectively assess the proportion of pwCF, including both adults and children with CF who have evidence of SARS-CoV-2 antibodies over a two-year period.This study…

Read more